What sector does Sanofi Cons Healthc Ind L belong to?

Sanofi Cons Healthc Ind L operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of SANOFICONR?

As of the latest available quote, SANOFICONR traded at ₹4,020.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of SANOFICONR?

Sanofi Cons Healthc Ind L has a price-to-earnings (P/E) ratio of about 34.81. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of SANOFICONR?

The market capitalisation of Sanofi Cons Healthc Ind L is approximately ₹9,266 Cr.

Is Sanofi Cons Healthc Ind L profitable?

For its latest reported financial year, Sanofi Cons Healthc Ind L recorded a net profit margin of about 27.33%.

Does SANOFICONR pay a dividend?

Sanofi Cons Healthc Ind L does not currently show a dividend yield in our data.

What is the return on equity (ROE) of SANOFICONR?

Sanofi Cons Healthc Ind L has a return on equity (ROE) of about 71.60%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of SANOFICONR?

Over the past 52 weeks, SANOFICONR has traded between a low of ₹3,975.00 and a high of ₹5,357.00.

Sanofi Cons Healthc Ind L

SANOFICONR NSE Healthcare Pharmaceuticals

Microcap 250

₹4,020.00

-1.70%

Delayed · cached 15 min

Fair value analysis

SANOFICONR

Sanofi Cons Healthc Ind L

₹4,089.60

Close used for this calculation

₹2,768.91Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

61/100

Profitability23/25

Returns11/25

Balance Sheet18/25

Efficiency9/25

Growth12/25

Good

Quality radar

Consensus fair value

₹2,768.91

Above FV

▼ -32.3% against the close used

Model range ₹631.82 – ₹4,107.59

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹631.82Fair value₹2,768.91Bull₹4,107.59

FairClose

52-week traded range

52W low ₹3,999.5052W high ₹5,292.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Sanofi Cons Healthc Ind L closed at ₹4,089.60, 47.7% above the consensus fair value of ₹2,768.91 drawn from 8 valuation models.

Financial DNA score 61/100 — Good. P/E of 34.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹2,069.26

-49.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹631.82

-84.6%

√(22.5 × EPS × BVPS)

EPS=104.25, BVPS=170.19 · outside Graham range (P/E 34.8, P/B 24) — asset-light, treat as a rough floor

P/E Fair Value

₹3,721.73

-9.0%

EPS × 35.7x (sector P/E)

EPS=104.25, Sector P/E=35.7x

Peter Lynch (PEG)

₹1,584.60

-61.3%

EPS × Growth% (PEG = 1 is fair)

EPS=104.25, g=15.2%

EV/EBITDA

₹2,484.21

-39.3%

(EBITDA × 17.6x − Net Debt) ÷ Shares

EBITDA=3.21B

Dividend Discount (DDM)

₹4,107.59

+0.4%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=76.07, r=10%, g=8%

Reverse DCF

₹4,089.60

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 16.2% | Historical: 15.2%

Margin of Safety

₹1,605.70

-60.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=2140.94, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer